Biotech · Public company · Boston, MA, US
PepGen Inc.
Ticker PEPG · SEC CIK 0001835597
Track this companyFree. Adds PepGen Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- PGN-EDODM1 for infusionPhase 1 · Myotonic Dystrophy 1ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1PHASE1 · COMPLETED · started Dec 12, 2023ClinicalTrials.gov NCT06204809 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 21, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 4, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 4, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 4, 2026 · fetched Nov 12, 2026